Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood

Journal of Clinical Virology

Volumn 51, Issue 1, 2011, Pages 31-37

  Ohga, Shouichi ^a   Ishimura, Masataka ^a   Yoshimoto, Goichi ^a   Miyamoto, Toshihiro ^a   Takada, Hidetoshi ^a   Tanaka, Tamami ^a   Ohshima, Koichi ^b   Ogawa, Yoshiyasu ^c   Imadome, Ken Ichi ^d   Abe, Yasunobu ^a   Akashi, Koichi ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

CD34 + cells; Chronic active Epstein Barr virus infection; Epstein Barr virus; Lymphoproliferative disease; Natural killer cells; T cells

Indexed keywords

ADULT; ALPHABETAT LYMPHOCYTE; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS INFECTION; FEMALE; GAMMADELTAT LYMPHOCYTE; HUMAN; INFANT; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE;

ADULT; ANTIGENS, CD34; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; CLONE CELLS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; JAPAN; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; PHENOTYPE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 79953748328     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.01.014     Document Type: Article

References (33)

1. Ohga S., Nomura A., Takada H., Hara T. Epstein-Barr virus associated diseases in childhood. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 2002, 44(3):203-215.
2. Kimura H., Hoshino Y., Hara S., Sugaya N., Kawada J., Shibata Y., et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 2005, 191(4):531-539.
3. Ohga S., Sanefuji M., Ishimura M., Nomura A., Torisu H., Kira R., et al. Epstein-Barr virus load in cerebrospinal fluid of patients with chronic active Epstein-Barr virus infection. Pediatr Infect Dis J 2008, 27(11):1027-1030.
4. Kasahara Y., Yachie A., Takei K., Kanegane C., Okada K., Ohta K., et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001, 98(6):1882-1888.
5. Ohga S., Nomura A., Takada H., Ihara K., Kawakami K., Yanai F., et al. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis 2001, 183(1):1-7.
6. Suzuki K., Ohshima K., Karube K., Suzumiya J., Ohga S., Ishihara S., et al. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 2004, 24(5):1165-1174.
7. Sato E., Ohga S., Kuroda H., Yoshiba F., Nishimura M., Nagasawa M., et al. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol 2008, 83(9):721-727.
8. Quintanilla-Martinez L., Kimura H., Jaffe E.S. EBV-positive T-cell lymphoproliferative disorders of childhood. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 278-291. International Agency for Research on Cancer, Lyon, France. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
9. Cohen J.I., Kimura H., Nakamura S., Ko Y.H., Jaffe E.S. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 2009, 20(9):1472-1482.
10. Ohshima K., Kimura H., Yoshino T., Kim C.W., Ko Y.H., Lee S.S., et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 2008, 58(4):209-217.
11. Elazary A.S., Wolf D.G., Amir G., Avni B., Rund D., Yehuda D.B., et al. Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients. J Clin Virol 2007, 40(2):156-159.
12. Okano M., Kawa K., Kimura H., Yachie A., Wakiguchi H., Maeda A., et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005, 80(1):64-69.
13. Miyamoto T., Weissman I.L., Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 2000, 97(13):7521-7526.
14. Ohga S., Kimura N., Takada H., Nagano M., Ohshima K., Nomura A., et al. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease. Am J Hematol 1999, 61(1):26-33.
15. Ohshima K., Karube K., Hamasaki M., Tutiya T., Yamaguchi T., Suefuji H., et al. Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases. Leuk Lymphoma 2003, 44(8):1367-1378.
16. Hudnall S.D., Ge Y., Wei L., Yang N.P., Wang H.Q., Chen T. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 2005, 18(4):519-527.
17. Imai S., Sugiura M., Oikawa O., Koizumi S., Hirao M., Kimura H., et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996, 87(4):1446-1457.
18. Oyoshi M.K., Nagata H., Kimura N., Zhang Y., Demachi A., Hara T., et al. Preferential expansion of Vγ9-JγP/Vδ2-Jδ3 γδ T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection. Am J Pathol 2003, 162(5):1629-1638.
19. Maini M.K., Gudgeon N., Wedderburn L.R., Rickinson A.B., Beverley P.C. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J Immunol 2000, 165(10):5729-5737.
20. Toyabe S., Harada W., Uchiyama M. Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection. Clin Exp Immunol 2003, 134(1):92-97.
21. Endo R., Yoshioka M., Ebihara T., Ishiguro N., Kikuta H., Kobayashi K. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection. Med Hypotheses 2004, 63(4):582-587.
22. Takakuwa T., Tresnasari K., Rahadiani N., Miwa H., Daibata M., Aozasa K. Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection. Leukemia 2008, 22(3):620-627.
23. Gao J., Luo X., Tang K., Li X., Li G. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji). J Virol Methods 2006, 136(1-2):193-199.
24. Shibata Y., Hoshino Y., Hara S., Yagasaki H., Kojima S., Nishiyama Y., et al. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection. J Med Virol 2006, 78(6):770-779.
25. Rey J., Xerri L., Bouabdallah R., Keuppens M., Brousset P., Meggetto F. Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient. Br J Haematol 2008, 142(1):79-81.
26. Katano H., Ali M.A., Patera A.C., Catalfamo M., Jaffe E.S., Kimura H., et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 2004, 103(4):1244-1252.
27. Tsuge I., Morishima T., Kimura H., Kuzushima K., Matsuoka H. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol 2001, 64(2):141-148.
28. Ma X., Okamura A., Yosioka M., Ishiguro N., Kikuta H., Kobayashi K. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan. J Med Virol 2001, 65(2):358-361.
29. Lee W.I., Chen S.H., Hung I.J., Yang C.P., Jaing T.H., Chen C.J., et al. Clinical aspects, immunologic assessment, and genetic analysis in Taiwanese children with hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J 2009, 28(1):30-34.
30. Repic A.M., Shi M., Scott R.S., Sixbey J.W. Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats. J Virol 2010, 84(5):2236-2244.
31. Alexaki A., Liu Y., Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 2008, 6(5):388-400.
32. Banerjee P., Sieburg M., Samuelson E., Feuer G. Human T-cell lymphotropic virus type 1 infection of CD34+ hematopoietic progenitor cells induces cell cycle arrest by modulation of p21(cip1/waf1) and survivin. Stem Cells 2008, 26(12):3047-3058.
33. Alexaki A., Wigdahl B. HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog 2008, 4(12):e1000215.